These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7529753)

  • 1. Vitamin D inhibits angiogenesis in transgenic murine retinoblastoma.
    Shokravi MT; Marcus DM; Alroy J; Egan K; Saornil MA; Albert DM
    Invest Ophthalmol Vis Sci; 1995 Jan; 36(1):83-7. PubMed ID: 7529753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antineoplastic effect of vitamin D in transgenic mice with retinoblastoma.
    Albert DM; Marcus DM; Gallo JP; O'Brien JM
    Invest Ophthalmol Vis Sci; 1992 Jul; 33(8):2354-64. PubMed ID: 1634333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subconjunctival carboplatin in fibrin sealant in the treatment of transgenic murine retinoblastoma.
    Van Quill KR; Dioguardi PK; Tong CT; Gilbert JA; Aaberg TM; Grossniklaus HE; Edelhauser HF; O'Brien JM
    Ophthalmology; 2005 Jun; 112(6):1151-8. PubMed ID: 15885791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicity and dose-response studies of 1,25-(OH)2-16-ene-23-yne vitamin D3 in transgenic mice.
    Wilkerson CL; Darjatmoko SR; Lindstrom MJ; Albert DM
    Clin Cancer Res; 1998 Sep; 4(9):2253-6. PubMed ID: 9748146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combretastatin A-4 prodrug in the treatment of a murine model of retinoblastoma.
    Escalona-Benz E; Jockovich ME; Murray TG; Hayden B; Hernandez E; Feuer W; Windle JJ
    Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):8-11. PubMed ID: 15623747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxicity and dose-response studies of 1-alpha hydroxyvitamin D2 in LH-beta-tag transgenic mice.
    Dawson DG; Gleiser J; Zimbric ML; Darjatmoko SR; Lindstrom MJ; Strugnell SA; Albert DM
    Ophthalmology; 2003 Apr; 110(4):835-9. PubMed ID: 12689912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of retinoblastoma tumor cell death after focal chemotherapy, radiation, and vascular targeting therapy in a mouse model.
    Jockovich ME; Suarez F; Alegret A; Piña Y; Hayden B; Cebulla C; Feuer W; Murray TG
    Invest Ophthalmol Vis Sci; 2007 Dec; 48(12):5371-6. PubMed ID: 18055783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local carboplatin therapy in transgenic murine retinoblastoma.
    Harbour JW; Murray TG; Hamasaki D; Cicciarelli N; Hernández E; Smith B; Windle J; O'Brien JM
    Invest Ophthalmol Vis Sci; 1996 Aug; 37(9):1892-8. PubMed ID: 8759359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antineoplastic effect of 1,25-dihydroxy-16-ene-23-yne-vitamin D3 analogue in transgenic mice with retinoblastoma.
    Shternfeld IS; Lasudry JG; Chappell RJ; Darjatmoko SR; Albert DM
    Arch Ophthalmol; 1996 Nov; 114(11):1396-401. PubMed ID: 8906031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subconjunctival topotecan in fibrin sealant in the treatment of transgenic murine retinoblastoma.
    Tsui JY; Dalgard C; Van Quill KR; Lee L; Grossniklaus HE; Edelhauser HF; O'Brien JM
    Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):490-6. PubMed ID: 18234990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1999 Feb; 469():1-361. PubMed ID: 12579204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased hypoxia following vessel targeting in a murine model of retinoblastoma.
    Boutrid H; Piña Y; Cebulla CM; Feuer WJ; Lampidis TJ; Jockovich ME; Murray TG
    Invest Ophthalmol Vis Sci; 2009 Dec; 50(12):5537-43. PubMed ID: 19578014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antineoplastic effect and toxicity of 1,25-dihydroxy-16-ene-23-yne-vitamin D3 in athymic mice with Y-79 human retinoblastoma tumors.
    Sabet SJ; Darjatmoko SR; Lindstrom MJ; Albert DM
    Arch Ophthalmol; 1999 Mar; 117(3):365-70. PubMed ID: 10088815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinoblastoma tumor vessel maturation impacts efficacy of vessel targeting in the LH(BETA)T(AG) mouse model.
    Jockovich ME; Bajenaru ML; Piña Y; Suarez F; Feuer W; Fini ME; Murray TG
    Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2476-82. PubMed ID: 17525173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo therapy of local tumor progression by targeting vascular endothelium with EMAP-II.
    Schwarz RE; Schwarz MA
    J Surg Res; 2004 Jul; 120(1):64-72. PubMed ID: 15172191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1alpha,25-(OH)(2)-D(3) and its synthetic analogue decrease tumor load in the Apc(min) Mouse.
    Huerta S; Irwin RW; Heber D; Go VL; Koeffler HP; Uskokovic MR; Harris DM
    Cancer Res; 2002 Feb; 62(3):741-6. PubMed ID: 11830528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NTP Toxicology and Carcinogenesis Studies of 3,4-Dihydrocoumarin (CAS No. 119-84-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 423():1-336. PubMed ID: 12616288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined anti-fetal liver kinase 1 monoclonal antibody and continuous low-dose doxorubicin inhibits angiogenesis and growth of human soft tissue sarcoma xenografts by induction of endothelial cell apoptosis.
    Zhang L; Yu D; Hicklin DJ; Hannay JA; Ellis LM; Pollock RE
    Cancer Res; 2002 Apr; 62(7):2034-42. PubMed ID: 11929822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paclitaxel in the treatment of retinal tumors of LH beta-Tag murine transgenic model of retinoblastoma.
    Suárez F; Jockovich ME; Hernandez E; Feuer W; Parel JM; Murray TG
    Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3437-40. PubMed ID: 17652710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.